Logo image of RVX.CA

RESVERLOGIX CORP (RVX.CA) Stock Overview

TSX:RVX - CA76128M1086 - Common Stock

0.1025 CAD
0 (-2.38%)
Last: 8/29/2025, 7:00:00 PM

RVX.CA Key Statistics, Chart & Performance

Key Statistics
52 Week High0.3
52 Week Low0.04
Market Cap29.36M
Shares286.44M
Float193.89M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.05
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10
IPO10-12 2001-10-12
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


RVX.CA short term performance overview.The bars show the price performance of RVX.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 40 60 80 100

RVX.CA long term performance overview.The bars show the price performance of RVX.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 -40 -60

The current stock price of RVX.CA is 0.1025 CAD. In the past month the price increased by 2.5%. In the past year, price increased by 13.89%.

RESVERLOGIX CORP / RVX Daily stock chart

RVX.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EDT.CA SPECTRAL MEDICAL INC N/A 425.87M
FRX.CA FENNEC PHARMACEUTICALS INC N/A 343.98M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 266.82M
TH.CA THERATECHNOLOGIES INC N/A 204.61M
HBP.CA HELIX BIOPHARMA CORP N/A 103.88M
WLLW.CA WILLOW BIOSCIENCES INC N/A 97.56M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 90.92M
BLU.CA BLUENERGIES LTD N/A 82.42M
NRX.CA NUREXONE BIOLOGIC INC N/A 66.41M
COV.CA COVALON TECHNOLOGIES LTD 18.46 65.81M
MSCL.CA SATELLOS BIOSCIENCE INC N/A 60.21M
SVA.CA SERNOVA BIOTHERAPEUTICS INC N/A 45.90M

About RVX.CA

Company Profile

RVX logo image Resverlogix Corp. engages in the research and development of pharmaceutical products for cardiovascular diseases. The company is headquartered in Calgary, Alberta and currently employs 18 full-time employees. The company went IPO on 2001-10-12. The firm focuses on the development of a new class of therapeutics: bromodomain and extraterminal domain (BET) protein inhibitors. BET proteins play a central role in epigenetics and enable the transcription of disease-causing genes. Its small molecule BET inhibitors are designed to exploit this central epigenetic role to regulate gene expression and tackle the root causes of chronic diseases. The firm's clinical program focuses on evaluating the lead epigenetic candidate apabetalone for the treatment of cardiovascular disease, associated comorbidities, and post-COVID-19 conditions. The company partners with EVERSANA to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

Company Info

RESVERLOGIX CORP

300-4820 Richard Rd SW

Calgary ALBERTA T3E 6L1 CA

CEO: Donald J. McCaffrey

Employees: 18

RVX Company Website

RVX Investor Relations

Phone: 14032549252

RESVERLOGIX CORP / RVX.CA FAQ

What is the stock price of RESVERLOGIX CORP today?

The current stock price of RVX.CA is 0.1025 CAD. The price decreased by -2.38% in the last trading session.


What is the ticker symbol for RESVERLOGIX CORP stock?

The exchange symbol of RESVERLOGIX CORP is RVX and it is listed on the Toronto Stock Exchange exchange.


On which exchange is RVX.CA stock listed?

RVX.CA stock is listed on the Toronto Stock Exchange exchange.


What is RESVERLOGIX CORP worth?

RESVERLOGIX CORP (RVX.CA) has a market capitalization of 29.36M CAD. This makes RVX.CA a Nano Cap stock.


How many employees does RESVERLOGIX CORP have?

RESVERLOGIX CORP (RVX.CA) currently has 18 employees.


What are the support and resistance levels for RESVERLOGIX CORP (RVX.CA) stock?

RESVERLOGIX CORP (RVX.CA) has a support level at 0.1 and a resistance level at 0.11. Check the full technical report for a detailed analysis of RVX.CA support and resistance levels.


Should I buy RESVERLOGIX CORP (RVX.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does RESVERLOGIX CORP (RVX.CA) stock pay dividends?

RVX.CA does not pay a dividend.


When does RESVERLOGIX CORP (RVX.CA) report earnings?

RESVERLOGIX CORP (RVX.CA) will report earnings on 2025-11-10.


What is the Price/Earnings (PE) ratio of RESVERLOGIX CORP (RVX.CA)?

RESVERLOGIX CORP (RVX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.05).


RVX.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to RVX.CA. When comparing the yearly performance of all stocks, RVX.CA is one of the better performing stocks in the market, outperforming 90.2% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

RVX.CA Financial Highlights

Over the last trailing twelve months RVX.CA reported a non-GAAP Earnings per Share(EPS) of -0.05. The EPS increased by 12.03% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -143.27%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%65.24%
Sales Q2Q%N/A
EPS 1Y (TTM)12.03%
Revenue 1Y (TTM)N/A

RVX.CA Forecast & Estimates


Analysts
Analysts80
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

RVX.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners2.56%
Short Float %N/A
Short RatioN/A